Augmentation of 11β-hydroxysteroid dehydrogenase type 1 in LPS-activated J774.1 macrophages - Role of 11β-HSD1 in pro-inflammatory properties in macrophages

FEBS Letters

Volumn 581, Issue 3, 2007, Pages 349-354

  Ishii, Takako ^a   Masuzaki, Hiroaki ^a   Tanaka, Tomohiro ^a   Arai, Naoki ^a   Yasue, Shintaro ^a   Kobayashi, Nozomi ^a   Tomita, Tsutomu ^a   Noguchi, Michio ^a   Fujikura, Junji ^a   Ebihara, Ken ^a   Hosoda, Kiminori ^a   Nakao, Kazuwa ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

11 HSD1; Adipocyte; Inflammation; Inhibitor; Macrophage; Metabolic syndrome

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CARBENOXOLONE; CYTOKINE; DEXAMETHASONE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; PRIMER DNA;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; INFLAMMATION; INSULIN RESISTANCE; MACROPHAGE ACTIVATION; METABOLIC SYNDROME X; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; ANIMAL; CELL LINE; DRUG EFFECT; ENZYMOLOGY; GENETICS; MACROPHAGE; METABOLISM; OBESITY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

MURINAE;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ADIPOCYTES; ANIMALS; BASE SEQUENCE; CELL LINE; DEXAMETHASONE; DNA PRIMERS; INFLAMMATION; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; OBESITY; RNA, MESSENGER;

EID: 33846413216     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.11.032     Document Type: Article

References (31)

1. Ford E.S., Giles W.H., and Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. Jama 287 (2002) 356-359
2. Bujalska I.J., Kumar S., and Stewart P.M. Does central obesity reflect "Cushing's disease of the omentum?. Lancet 349 (1997) 1210-1213
3. Jamieson P.M., Chapman K.E., Edwards C.R., and Seckl J.R. 11β-hydroxysteroid dehydrogenase is an exclusive 11 beta-reductase in primary cultures of rat hepatocytes: effect of physicochemical and hormonal manipulations. Endocrinology 136 (1995) 4754-4761
4. Wake D.J., and Walker B.R. 11 beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome. Mol. Cell Endocrinol. 215 (2004) 45-54
5. Masuzaki H., Paterson J., Shinyama H., Morton N.M., Mullins J.J., Seckl J.R., and Flier J.S. A transgenic model of visceral obesity and the metabolic syndrome. Science 294 (2001) 2166-2170
6. Masuzaki H., et al. Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. J. Clin. Invest. 112 (2003) 83-90
7. Morton N.M., et al. Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice. Diabetes 53 (2004) 931-938
8. Kotelevtsev Y., et al. 11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proc. Natl. Acad. Sci. USA 94 (1997) 14924-14929
9. Harris H.J., Kotelevtsev Y., Mullins J.J., Seckl J.R., and Holmes M.C. Intracellular regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase (11beta-HSD)-1 plays a key role in regulation of the hypothalamic-pituitary-adrenal axis: analysis of 11beta-HSD-1-deficient mice. Endocrinology 142 (2001) 114-120
10. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., and Ferrante Jr. A.W. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112 (2003) 1796-1808
11. Xu H., et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112 (2003) 1821-1830
12. Suganami T., Nishida J., and Ogawa Y. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. Arterioscler. Thromb. Vasc. Biol. 25 (2005) 2062-2068
13. Ralph P., and Nakoinz I. Phagocytosis and cytolysis by a macrophage tumour and its cloned cell line. Nature 257 (1975) 393-394
14. Andrews R.C., Rooyackers O., and Walker B.R. Effects of the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes. J. Clin. Endocrinol. Metab. 88 (2003) 285-291
15. Sandeep T.C., Andrew R., Homer N.Z., Andrews R.C., Smith K., and Walker B.R. Increased in vivo regeneration of cortisol in adipose tissue in human obesity and effects of the 11beta-hydroxysteroid dehydrogenase type 1 inhibitor carbenoxolone. Diabetes 54 (2005) 872-879
16. Hermanowski-Vosatka A., et al. 11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice. J. Exp. Med. 202 (2005) 517-527
17. Hult M., et al. Active site variability of type 1 11beta-hydroxysteroid dehydrogenase revealed by selective inhibitors and cross-species comparisons. Mol. Cell Endocrinol. 248 (2006) 26-33
18. Wang S.J., et al. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 reduces food intake and weight gain but maintains energy expenditure in diet-induced obese mice. Diabetologia 49 (2006) 1333-1337
19. Poltorak A., et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282 (1998) 2085-2088
20. Hoshino K., Takeuchi O., Kawai T., Sanjo H., Ogawa T., Takeda Y., Takeda K., and Akira S. Cutting edge: toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162 (1999) 3749-3752
21. Lee J.Y., Sohn K.H., Rhee S.H., and Hwang D. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J. Biol. Chem. 276 (2001) 16683-16689
22. Yang S.Q., Lin H.Z., Lane M.D., Clemens M., and Diehl A.M. Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc. Natl. Acad. Sci. USA 94 (1997) 2557-2562
23. Rhen T., and Cidlowski J.A. Antiinflammatory action of glucocorticoids - new mechanisms for old drugs. N. Engl. J. Med. 353 (2005) 1711-1723
24. Barber A.E., Coyle S.M., Marano M.A., Fischer E., Calvano S.E., Fong Y., Moldawer L.L., and Lowry S.F. Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. J. Immunol. 150 (1993) 1999-2006
25. Liao J., Keiser J.A., Scales W.E., Kunkel S.L., and Kluger M.J. Role of corticosterone in TNF and IL-6 production in isolated perfused rat liver. Am. J. Physiol. 268 (1995) R699-R706
26. Sapolsky R.M., Romero L.M., and Munck A.U. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr. Rev. 21 (2000) 55-89
27. Smyth G.P., Stapleton P.P., Freeman T.A., Concannon E.M., Mestre J.R., Duff M., Maddali S., and Daly J.M. Glucocorticoid pretreatment induces cytokine overexpression and nuclear factor-kappaB activation in macrophages. J. Surg. Res. 116 (2004) 253-261
28. Gilmour J.S., et al. Local amplification of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1 promotes macrophage phagocytosis of apoptotic leukocytes. J. Immunol. 176 (2006) 7605-7611
29. Alberts P., et al. Selective inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 improves hepatic insulin sensitivity in hyperglycemic mice strains. Endocrinology 144 (2003) 4755-4762
30. Paulmyer-Lacroix O., Boullu S., Oliver C., Alessi M.C., and Grino M. Expression of the mRNA coding for 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue from obese patients: an in situ hybridization study. J. Clin. Endocrinol. Metab. 87 (2002) 2701-2705
31. Rodbell M. Localization of lipoprotein lipase in fat cells of rat adipose tissue. J. Biol. Chem. 239 (1964) 753-755